Netrin-1 overexpression is predictive of ovarian malignancies

por Papanastasiou, Anastasios D., Pampalakis, Georgios, Katsaros, Dionyssios, Sotiropoulou, Georgia
Publicado 2011

Genotyping of stathmin and its association with clinical factors and survival in patients with ovarian cancer

por YING, LISHA, SU, DAN, ZHU, JIANQING, MA, SHENGLIN, KATSAROS, DIONYSSIOS, YU, HERBERT
Publicado 2013

Low expression of WWC1, a tumor suppressor gene, is associated with aggressive breast cancer and poor survival outcome

por Wang, Zhanwei, Katsaros, Dionyssios, Biglia, Nicoletta, Shen, Yi, Fu, Yuanyuan, Tiirikainen, Maarit, Yu, Herbert
Publicado 2019

Immune Checkpoint Inhibitors in Epithelial Ovarian Cancer: An Overview on Efficacy and Future Perspectives

por Borella, Fulvio, Ghisoni, Eleonora, Giannone, Gaia, Cosma, Stefano, Benedetto, Chiara, Valabrega, Giorgio, Katsaros, Dionyssios
Publicado 2020

LncRNA ZNF582-AS1 Expression and Methylation in Breast Cancer and Its Biological and Clinical Implications

por Wang, Junlong, Katsaros, Dionyssios, Biglia, Nicoletta, Fu, Yuanyuan, Benedetto, Chiara, Loo, Lenora, Wang, Zhanwei, Yu, Herbert
Publicado 2022

Telomerase expression and telomere length in breast cancer and their associations with adjuvant treatment and disease outcome

por Lu, Lingeng, Zhang, Chong, Zhu, Gongjian, Irwin, Melinda, Risch, Harvey, Menato, Guido, Mitidieri, Marco, Katsaros, Dionyssios, Yu, Herbert
Publicado 2011

Machine learning-based cluster analysis of immune cell subtypes and breast cancer survival

por Wang, Zhanwei, Katsaros, Dionyssios, Wang, Junlong, Biglio, Nicholetta, Hernandez, Brenda Y., Fei, Peiwen, Lu, Lingeng, Risch, Harvey, Yu, Herbert
Publicado 2023

High PTPN13 expression in high grade serous ovarian carcinoma is associated with a better patient outcome

por D’Hondt, Véronique, Lacroix-Triki, Magalie, Jarlier, Marta, Boissiere-Michot, Florence, Puech, Carole, Coopman, Peter, Katsaros, Dionyssios, Freiss, Gilles
Publicado 2017

PDCD6 is an independent predictor of progression free survival in epithelial ovarian cancer

por Su, Dan, Xu, Haiyan, Feng, Jianguo, Gao, Yun, Gu, Linhui, Ying, Lisha, Katsaros, Dionyssios, Yu, Herbert, Xu, Shenhua, Qi, Ming
Publicado 2012

Vitamin D receptor upregulates lncRNA TOPORS-AS1 which inhibits the Wnt/β-catenin pathway and associates with favorable prognosis of ovarian cancer

por Fu, Yuanyuan, Katsaros, Dionyssios, Biglia, Nicoletta, Wang, Zhanwei, Pagano, Ian, Tius, Marcus, Tiirikainen, Maarit, Rosser, Charles, Yang, Haining, Yu, Herbert
Publicado 2021

Hormone Receptors and Epithelial Ovarian Cancer: Recent Advances in Biology and Treatment Options

por Borella, Fulvio, Fucina, Stefano, Mangherini, Luca, Cosma, Stefano, Carosso, Andrea Roberto, Cusato, Jessica, Cassoni, Paola, Bertero, Luca, Katsaros, Dionyssios, Benedetto, Chiara
Publicado 2023

Biological and Clinical Significance of MAD2L1 and BUB1, Genes Frequently Appearing in Expression Signatures for Breast Cancer Prognosis

por Wang, Zhanwei, Katsaros, Dionyssios, Shen, Yi, Fu, Yuanyuan, Canuto, Emilie Marion, Benedetto, Chiara, Lu, Lingeng, Chu, Wen-Ming, Risch, Harvey A., Yu, Herbert
Publicado 2015

Expression of Activated PIK3CA in Ovarian Surface Epithelium Results in Hyperplasia but Not Tumor Formation

por Liang, Shun, Yang, Nuo, Pan, Yue, Deng, Shan, Lin, Xiaojuan, Yang, Xiaojun, Katsaros, Dionyssios, Roby, Katherine F., Hamilton, Thomas C., Connolly, Denise C., Coukos, George, Zhang, Lin
Publicado 2009

Prognostic and predictive values of long non-coding RNA LINC00472 in breast cancer

por Shen, Yi, Katsaros, Dionyssios, Loo, Lenora W. M., Hernandez, Brenda Y., Chong, Clayton, Canuto, Emilie Marion, Biglia, Nicoletta, Lu, Lingeng, Risch, Harvey, Chu, Wen-Ming, Yu, Herbert
Publicado 2015

Xenopatients show the need for precision medicine approach to chemotherapy in ovarian cancer

por Erriquez, Jessica, Olivero, Martina, Mittica, Gloria, Scalzo, Maria Stella, Vaira, Marco, De Simone, Michele, Ponzone, Riccardo, Katsaros, Dionyssios, Aglietta, Massimo, Calogero, Raffaele, Di Renzo, Maria Flavia, Valabrega, Giorgio
Publicado 2016

Brain Metastases from Ovarian Cancer: Current Evidence in Diagnosis, Treatment, and Prognosis

por Borella, Fulvio, Bertero, Luca, Morrone, Antonio, Gambella, Alessandro, Bovetti, Marialuisa, Cosma, Stefano, Carosso, Andrea, Katsaros, Dionyssios, Gemmiti, Silvia, Preti, Mario, Valabrega, Giorgio, Scotto, Giulia, Cassoni, Paola, Benedetto, Chiara
Publicado 2020

Transcriptional Regulation of PIK3CA Oncogene by NF-κB in Ovarian Cancer Microenvironment

por Yang, Nuo, Huang, Jia, Greshock, Joel, Liang, Shun, Barchetti, Andrea, Hasegawa, Kosei, Kim, Sarah, Giannakakis, Antonis, Li, Chunsheng, O'Brien-Jenkins, Anne, Katsaros, Dionyssios, Bützow, Ralf, Coukos, George, Zhang, Lin
Publicado 2008

TOP2A as marker of response to pegylated lyposomal doxorubicin (PLD) in epithelial ovarian cancers

por Ghisoni, Eleonora, Maggiorotto, Furio, Borella, Fulvio, Mittica, Gloria, Genta, Sofia, Giannone, Gaia, Katsaros, Dionyssios, Sciarrillo, Alberto, Ferrero, Annamaria, Sarotto, Ivana, Erriquez, Jessica, Di Renzo, Maria Flavia, Aglietta, Massimo, Valabrega, Giorgio
Publicado 2019

A predictive score for optimal cytoreduction at interval debulking surgery in epithelial ovarian cancer: a two- centers experience

por Ghisoni, Eleonora, Katsaros, Dionyssios, Maggiorotto, Furio, Aglietta, Massimo, Vaira, Marco, De Simone, Michele, Mittica, Gloria, Giannone, Gaia, Robella, Manuela, Genta, Sofia, Lucchino, Fabiola, Marocco, Francesco, Borella, Fulvio, Valabrega, Giorgio, Ponzone, Riccardo
Publicado 2018

FXYD5 (Dysadherin) upregulation predicts shorter survival and reveals platinum resistance in high-grade serous ovarian cancer patients

por Tassi, Renata A., Gambino, Angela, Ardighieri, Laura, Bignotti, Eliana, Todeschini, Paola, Romani, Chiara, Zanotti, Laura, Bugatti, Mattia, Borella, Fulvio, Katsaros, Dionyssios, Tognon, Germana, Sartori, Enrico, Odicino, Franco, Romualdi, Chiara, Ravaggi, Antonella
Publicado 2019